Having been assembled in January 2021, the IMC has sought to gain support in favour of holistic management and pandemic preparedness, following the impact the COVID-19 pandemic has had on societies and economies worldwide.
The IMC comprises of leading health professionals, the scientific community and industry, working together – with the involvement of the government – with the shared goal of implementing a more cohesive approach to infection management.
The IMC partners are Antibiotic Research UK, the Association of British HealthTech Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), BD, bioMérieux, the British In Vitro Diagnostics Association (BIVDA), the British Society for Antimicrobial Chemotherapy (BSAC), Menarini UK, Pfizer UK, Roche Diagnostics UK, Thermo Fisher Scientific and the UK Sepsis Trust…